SANTA MONICA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that CEO Matthew L. Schissler was interviewed by the leading biotechnology publication in Greece, where Cord Blood America established a partnership in 2006 named a.bourkas Co., United.
"Stem cells are used today in the treatment of leukemia, breast cancer, lymphoma, Hodgkin's Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders," Mr. Schissler said in the interview. "As stem cell transplants become routine, they may be used to fight many other cancers, viruses and genetic disorders."
"Umbilical cord stem cells are used to repopulate one's immune system. An example would be a leukemia patient who undergoes radiation therapy. The stem cells from the umbilical cord repopulate the patient's immune system with healthy cells to keep the body strong and to help fight other diseases," Cord Blood America's CEO said.
Mr. Schissler further explained that, "umbilical cord stem cells are a perfect match for the baby, but because of close genetic ties, there is a good chance they will match for immediate family members as well. They also may be a very good match for a sibling. Umbilical cord stem cells are the best because they have hematapoletic traits, meaning they repopulate the immune system and have regenerative traits meaning they can regenerate tissue."
Andreas Bourkas, Director and Manager of a.bourkas Co., United, said saving the umbilical cord at birth is starting to be a popular choice. "Greek's have very strong family ties and this is exactly the right step for a family to take," Mr. Bourkas said. Mr. Schissler said this is Cord Blood America's first international business and the success of the business model could lead to introducing the concept in other countries."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
CorCell, which facilitates umbilical cord blood stem cell preservation for
expectant parents and their children. Its mission is to be the most
respected stem cell preservation company in the industry. Collected through
a safe and non-invasive process, cord blood stem cells offer a powerful and
potentially life-saving resource for treating a growing number of ailments,
including cancer, leukemia, blood, and immune disorders. To find out more
about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our
website at http://www.corcell.com. For investor information, visit
E & E Communications
|SOURCE Cord Blood America, Inc.|
Copyright©2008 PR Newswire.
All rights reserved